Free tool
Diagnostics stocks
We cover 8 companies grouped under the Diagnostics theme. The median market value in the group is $398.15M. Across the group, the median move over the past trading day is +1.07%. Price change over the past year runs from −16.7% to +21.8% across the middle 80 percent of the group, with a median of −9.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% | Nov 4, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% | Oct 21, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.53% | Sep 10, 2026 |
| CEVI.ST | CellaVision AB (publ) | $413.78M | Small cap | −3.32% | Oct 28, 2026 |
| NIOX.L | NIOX Group Plc | $382.51M | Small cap | −6.05% | Sep 29, 2026 |
| 0KCC.L | Insight Molecular Diagnostics Inc. | $339.65M | Small cap | +80.26% | Nov 9, 2026 |
| SBS.DE | Stratec SE | $324.34M | Small cap | −16.29% | Nov 12, 2026 |
| 0RAR.L | Stratec SE | $275.63M | Small cap | −13.37% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.